GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $373,396,000 | -6.0% | 8,507,405 | -5.4% | 0.02% | +10.0% |
| Q1 2022 | $397,398,000 | -1.1% | 8,994,904 | -0.1% | 0.02% | +5.3% |
| Q4 2021 | $402,013,000 | +14.3% | 9,007,976 | -0.8% | 0.02% | 0.0% |
| Q3 2021 | $351,772,000 | -4.9% | 9,079,035 | -0.9% | 0.02% | 0.0% |
| Q2 2021 | $369,759,000 | +8.6% | 9,163,297 | -2.2% | 0.02% | -5.0% |
| Q1 2021 | $340,424,000 | -4.0% | 9,373,894 | -1.4% | 0.02% | -9.1% |
| Q4 2020 | $354,623,000 | -0.9% | 9,510,345 | +1.3% | 0.02% | -8.3% |
| Q3 2020 | $357,910,000 | -6.9% | 9,390,232 | +0.8% | 0.02% | -14.3% |
| Q2 2020 | $384,283,000 | +9.5% | 9,317,126 | +2.1% | 0.03% | -9.7% |
| Q1 2020 | $351,063,000 | -18.9% | 9,123,000 | +0.0% | 0.03% | +3.3% |
| Q4 2019 | $433,074,000 | +6.5% | 9,121,751 | -3.2% | 0.03% | 0.0% |
| Q3 2019 | $406,683,000 | +3.5% | 9,425,973 | -2.8% | 0.03% | +3.4% |
| Q2 2019 | $392,990,000 | -4.6% | 9,701,155 | -0.2% | 0.03% | -9.4% |
| Q1 2019 | $411,997,000 | +7.7% | 9,720,629 | -1.6% | 0.03% | -8.6% |
| Q4 2018 | $382,418,000 | -4.2% | 9,883,390 | -0.5% | 0.04% | +12.9% |
| Q3 2018 | $399,034,000 | -1.0% | 9,933,608 | -0.7% | 0.03% | -8.8% |
| Q2 2018 | $403,100,000 | +2.0% | 10,000,022 | -1.1% | 0.03% | 0.0% |
| Q1 2018 | $395,077,000 | +8.5% | 10,112,019 | -1.5% | 0.03% | +17.2% |
| Q4 2017 | $363,984,000 | -13.1% | 10,261,757 | -0.5% | 0.03% | -19.4% |
| Q3 2017 | $418,701,000 | -6.1% | 10,312,810 | -0.2% | 0.04% | -7.7% |
| Q2 2017 | $445,715,000 | +0.8% | 10,336,607 | -1.5% | 0.04% | 0.0% |
| Q1 2017 | $442,338,000 | +8.4% | 10,491,299 | -1.0% | 0.04% | +2.6% |
| Q4 2016 | $408,238,000 | -9.2% | 10,600,829 | +1.7% | 0.04% | -15.6% |
| Q3 2016 | $449,426,000 | -1.0% | 10,420,261 | -0.5% | 0.04% | -8.2% |
| Q2 2016 | $453,884,000 | +8.0% | 10,472,620 | +1.1% | 0.05% | +8.9% |
| Q1 2016 | $420,149,000 | +0.7% | 10,361,271 | +0.2% | 0.04% | -2.2% |
| Q4 2015 | $417,098,000 | +4.4% | 10,337,024 | -0.6% | 0.05% | -2.1% |
| Q3 2015 | $399,708,000 | -8.6% | 10,395,524 | -1.0% | 0.05% | 0.0% |
| Q2 2015 | $437,237,000 | -11.1% | 10,497,901 | -1.5% | 0.05% | -6.0% |
| Q1 2015 | $491,986,000 | +7.4% | 10,660,587 | -0.5% | 0.05% | +8.7% |
| Q4 2014 | $458,103,000 | -7.7% | 10,718,376 | -0.7% | 0.05% | -13.2% |
| Q3 2014 | $496,188,000 | -14.2% | 10,793,744 | -0.2% | 0.05% | -14.5% |
| Q2 2014 | $578,118,000 | -0.6% | 10,809,995 | -0.7% | 0.06% | -6.1% |
| Q1 2014 | $581,427,000 | -46.0% | 10,882,049 | -51.2% | 0.07% | -4.3% |
| Q4 2013 | $1,077,370,000 | +94.3% | 22,291,888 | +101.7% | 0.07% | +1.5% |
| Q3 2013 | $554,617,000 | -0.9% | 11,054,738 | -1.3% | 0.07% | -6.8% |
| Q2 2013 | $559,695,000 | – | 11,200,614 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |